| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 638241 | Null | 0.00336064452966832 | 0.42849733 |
| NSC 639520 | Cyclohexanone, 2-[(2-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride | 0.00336064452966832 | 0.35422784 |
| NSC 659390 | Null | 0.00336064452966832 | 0.42441558 |
| NSC 376739 | 5,12-Naphthacenedione, 10-[(2,6-dideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- | 0.00356914129105574 | 0.32392898 |
| NSC 382034 | 2,4-Pyrimidinediamine, 6-ethyl-5-[4-(methylamino)- 3-nitrophenyl]- | 0.00356914129105574 | 0.47057342 |
| NSC 654509 | Pirarubicin HCl | 0.00356914129105574 | 0.38907173 |
| NSC 670226 | trans-2((1-(4-fluorphenyl-methyl)-4-tert.butylcyclohexyl)oxy)N,N-dimethyl-1-ethanamine-, salt with fumaric acid | 0.00356914129105574 | 0.2750083 |
| NSC 673348 | 9,10-Anthracenedione, 1-[(oxiranylmethyl)amino]- | 0.00356914129105574 | 0.39431201 |
| NSC 692579 | Null | 0.00356914129105574 | 0.41855992 |
| NSC 740 | Methotrexate | 0.00356914129105577 | 0.50105045 |